Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To demonstrate that epoetin alfa treatment is better at improving anemia outcome (as evaluated by Erythroid response – International Working Group [IWG] 2006) in subjects with International Prognostic Scoring Systems (IPSS) Low- or Intermediate-1-risk myelodysplastic syndromes (MDS), compared with placebo, through Week 24.
Inclusion criteria
- Anemic Patients With IPSS Low- or Intermediate-1-Risk Myelodysplastic Syndromes